{
    "source": {
        "id": "techcrunch",
        "name": "TechCrunch"
    },
    "author": "Darrell Etherington",
    "title": "Emergent BioSolutions gets $14.5M in federal funding to expedite COVID-19 plasma therapy development",
    "description": "Last week, we spoke to the Head of Emergent BioSolutions\u2019 Therapeutics Business Unit Dr. Laura Saward about her company\u2019s work developing plasma-based potential treatments for COVID-19. Now, the company announced that it has received $14.5 million in funding \u2026",
    "url": "http://techcrunch.com/2020/04/03/emergent-biosolutions-gets-14-5m-in-federal-funding-to-expedite-covid-19-plasma-therapy-development/",
    "urlToImage": "https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1210900116.jpeg?w=640",
    "publishedAt": "2020-04-03T16:54:36Z",
    "content": "Last week, we spoke to the Head of Emergent BioSolutions\u2019 Therapeutics Business Unit Dr. Laura Saward about her company\u2019s work developing plasma-based potential treatments for COVID-19. Now, the company announced that it has received $14.5 million in funding \u2026 [+2066 chars]"
}